SCHEMBL8765387

SCHEMBL8765387

CS(=O)(=O)c1ccc(-c2cc(C(F)(F)F)nn2-c2ccccc2)cc1

nearest known ligand 0.90

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 11/20 0.90
PTGS1 P23219 4/20 0.79
CYP2C9 P11712 2/20 0.79
PDPK1 O15530 3/20 0.70
ALOX5 P09917 2/20 0.62
PTGES O14684 1/20 0.62
HDAC3 O15379 1/20 0.62
CA12 O43570 1/20 0.62
PDE5A O76074 1/20 0.62
ABCB11 O95342 1/20 0.62
MT-CO2 P00403 1/20 0.62
CA1 P00915 1/20 0.62
CA2 P00918 1/20 0.62
LMNA P02545 1/20 0.62
CA3 P07451 1/20 0.62
CYP3A4 P08684 1/20 0.62
ADORA3 P0DMS8 1/20 0.62
CYP2D6 P10635 1/20 0.62
ADRB3 P13945 1/20 0.62
ALOX15 P16050 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8610309 0.95 PTGS2 (1.00) PTGS2PTGS1CYP2C9PDPK1ALOX5
SCHEMBL13943924 0.91 PTGS2 (0.75) PTGS2PTGS1CYP2C9PDPK1ALOX5
SCHEMBL6957077 0.90 PTGS2 (0.80) PTGS2PTGS1CYP2C9PDPK1ALOX5
SCHEMBL9088072 0.90 PTGS2 (0.80) PTGS2PTGS1CYP2C9PDPK1
SCHEMBL8954103 0.88 PTGS2 (0.81) PTGS2PTGS1CYP2C9PDPK1ALOX5
Sc-58125 SCHEMBL12375146 0.88 PTGS2 (1.00) PTGS2PTGS1CYP2C9PDPK1ALOX5
SCHEMBL5229949 0.88 PTGS2 (1.00) PTGS2PTGS1CYP2C9PDPK1ALOX5
Sc-58125 SCHEMBL214120 0.88 PTGS2 (1.00) PTGS2PTGS1CYP2C9PDPK1ALOX5
SCHEMBL8953888 0.88 PTGS2 (1.00) PTGS2PTGS1CYP2C9PDPK1ALOX5
SCHEMBL6378189 0.88 PTGS2 (1.00) PTGS2PTGS1CYP2C9PDPK1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1045767-C Pyrazole derivatives processes for preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1999-10-20 CN disclosed
EP-0731794-B1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1997-08-06 EP disclosed
US-5639777-A 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders G.D. SEARLE & CO. (US) 1997-06-17 US disclosed
EP-0731794-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1996-09-18 EP disclosed
WO-1995015317-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS G.D. SEARLE & CO. (US) 1995-06-08 WO disclosed
US-5401765-A FOR TREATING ARTHRITIS, PAIN AND FEVER Searle, G. D. (US) 1995-03-28 US disclosed